As summarized in Table 1, the high expression of C14orf166 was significantly associated with T classification (P=0.006), lymph node metastasis (P=0.001), TNM stage (P<0.001), and chemotherapy (P<0.001). The gene discussed is RTRAF; the disease is metastatic malignant neoplasm in the lymph nodes.